This review highlights advances and ongoing controversies in the diagnosis and treatment of acute pulmonary embolism, including anticoagulation duration, IVC filters, and thrombolytic therapy.
Answers are grounded in this paper and cite their sources.
Controversies persist in acute PE management; leaves open optimal anticoagulation duration, IVC filter use, and thrombolysis pending definitive trials.
Over the past two decades, considerable progress in technology and clinical research methods have led to advances in the diagnosis, treatment and prevention of acute venous thromboembolism. Despite this, however, the diagnosis is still often missed and preventive methods are often ignored. Published guidelines are useful, but are limited by the existing evidence base so that controversies remain with regard to topics such as duration of anticoagulation, indications for placement and removal of inferior vena caval filters, and when and how to administer thrombolytic therapy. The morbidity and mortality of this disease remain high, particularly when undiagnosed. While preventive approaches remain crucial, the focus of this review is on the diagnostic and therapeutic approach to acute venous thromboembolism, with an emphasis on acute pulmonary embolism.
No takes yet. Share an insight, caveat, or question.
Victor F. Tapson (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: